Cisplatin plus Gemcitabine Chemotherapy in Taxane/Anthracycline-Resistant Metastatic Breast Cancer

Publisher： Karger

E-ISSN： 1421-9794|55|3|155-160

ISSN： 0009-3157

Source： Chemotherapy, Vol.55, Iss.3, 2009-04, pp. : 155-160

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Gemcitabine and Vinorelbine Combination Chemotherapy in Taxane-Pretreated Patients with Metastatic Breast Cancer: A Phase II Study of the Kinki Multidisciplinary Breast Oncology Group (KMBOG) 1015

By  

Chemotherapy, Vol. 62, Iss. 5, 2017-06 ,pp. : 307-313

Karger

Access to resources Recommend Favorite

Gemcitabine plus Cisplatin versus Capecitabine plus Cisplatin as First-Line Chemotherapy for Advanced Biliary Tract Cancer: A Retrospective Cohort Study

By  

Chemotherapy, Vol. 59, Iss. 3, 2013-12 ,pp. : 232-238

Karger

Access to resources Recommend Favorite

Gemcitabine and Capecitabine Combination Chemotherapy in Patients with Metastatic Breast Cancer Pretreated with Anthracyclines and/or Taxanes

By  

Chemotherapy, Vol. 61, Iss. 4, 2016-02 ,pp. : 171-178

Karger

Access to resources Recommend Favorite

Significance of Tumor-Infiltrating Lymphocytes and the Expression of Topoisomerase IIα in the Prediction of the Clinical Outcome of Patients with Triple-Negative Breast Cancer after Taxane-Anthracycline-Based Neoadjuvant Chemotherapy

By  

Chemotherapy, Vol. 62, Iss. 4, 2017-05 ,pp. : 246-255

Karger

Access to resources Recommend Favorite

Cisplatin plus Capecitabine as First-Line Chemotherapy for Recurrent or Metastatic Head and Neck Squamous Cell Cancer: Experience Outside of a Trial Setting

By  

Chemotherapy, Vol. 59, Iss. 1, 2013-04 ,pp. : 1-7

Karger

Access to resources Recommend Favorite